Aggressive Immunosuppression Minimization Shortens BK Viremia, Does Not Improve Outcome, but Increases the Risk of De Novo Donor Specific Antibodies in Kidney Recipients.

被引:0
作者
Devresse, A. [1 ,2 ]
Tinel, C. [1 ]
Vermorel, A. [1 ]
Snanoudj, R. [1 ]
Morin, L. [1 ]
Avettand-Fenoel, V. [3 ]
Amrouche, L. [1 ]
Scemla, A. [1 ]
Zuber, J. [1 ]
Legendre, C. [1 ]
Rabant, M. [4 ]
Anglicheau, D. [1 ]
机构
[1] Hop Necker Enfants Malad, Nephrol & Kidney Transplantat, Paris, France
[2] Univ Hosp St Luc, Nephrol, Brussels, Belgium
[3] Hop Necker Enfants Malad, Virol, Paris, France
[4] Hop Necker Enfants Malad, Pathol, Paris, France
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
136
引用
收藏
页码:299 / 299
页数:1
相关论文
共 50 条
[31]   DQ Molecules Are The Principal Stimulators of De Novo Donor Specific Antibodies in Non Sensitized Pediatric Kidney Recipients [J].
Nocera, A. ;
Tagliamacco, A. ;
Cioni, M. ;
Comoli, P. ;
Cardillo, M. ;
Fontana, I. ;
Trivelli, A. ;
Ramondetta, M. ;
Magnasco, A. ;
Biticchi, R. ;
Ghiggeri, G. ;
Garibotto, G. ;
Ginevri, F. .
TRANSPLANTATION, 2014, 98 :62-62
[32]   BK polyomavirus DNAemia, allograft rejection, and de novo donor-specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients [J].
Huang, Hou-Xuan ;
Xiang, Yijin ;
George, Roshan ;
Winterberg, Pamela ;
Serluco, Anastacia ;
Liverman, Rochelle ;
Yildirim, Inci ;
Garro, Rouba .
PEDIATRIC TRANSPLANTATION, 2024, 28 (05)
[33]   Association of CXCR5 Polymorphisms with Detection of De Novo Donor Specific Antibodies in Kidney Transplant Recipients [J].
Ono, K. ;
Ide, K. ;
Nakano, R. ;
Sakai, H. ;
Tanimine, N. ;
Tahara, H. ;
Ohira, M. ;
Tanaka, Y. ;
Ohdan, H. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) :S489-S490
[34]   The Impact of Tacrolimus IPV and TTR on the Development of De Novo Donor-specific Antibodies in Kidney Transplant Recipients [J].
Xu, D. ;
Richards, K. ;
Zheng, K. ;
Patel, H. ;
Cardarelli, F. ;
Pena, J. A. ;
Aala, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 :844-844
[35]   DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN PEDIATRIC RECIPIENTS OF FIRST KIDNEY TRANSPLANTATION PREDICT GRAFT OUTCOME IRRESPECTIVE OF OCCURRENCE TIME [J].
Nocera, Arcangelo ;
Cioni, Michela ;
Tagliamacco, Augusto ;
Comoli, Patrizia ;
Cardillo, Massimo ;
Nocco, Angela ;
Sioli, Viviana ;
Trivelli, Antonella ;
Magnasco, Alberto ;
Verrina, Enrico ;
Ghiggeri, Gian Marco ;
Ginevri, Fabrizio .
TRANSPLANT INTERNATIONAL, 2015, 28 :71-71
[36]   Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation [J].
Li, Xiaobei ;
Ishida, Hideki ;
Yamaguchi, Yutaka ;
Tanabe, Kazunari .
TRANSPLANT INTERNATIONAL, 2008, 21 (12) :1145-1152
[37]   Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodies [J].
Croze, Laure-Emmanuelle ;
Tetaz, Rachel ;
Roustit, Matthieu ;
Malvezzi, Paolo ;
Janbon, Benedicte ;
Jouve, Thomas ;
Pinel, Nicole ;
Masson, Dominique ;
Quesada, Jean-Louis ;
Bayle, Francois ;
Zaoui, Philippe .
TRANSPLANT INTERNATIONAL, 2014, 27 (08) :775-783
[38]   PERSISTENCE OF DE NOVO DONOR SPECIFIC HLA-ANTIBODIES INCREASES THE RISK OF LUNG ALLOGRAFT DYSFUNCTION [J].
Schmitzer, M. ;
Kneidinger, N. ;
Dick, A. ;
Neurohr, C. ;
von Dossow, V. ;
Schramm, R. ;
Winter, H. ;
Kauke, T. .
TRANSPLANT INTERNATIONAL, 2016, 29 :14-15
[39]   Association between Respiratory Virus Infections and the Development of De Novo HLA Donor-Specific Antibodies in Lung Transplant Recipients. [J].
Ali, M. I. ;
Hata, J. ;
Mallea, J. ;
Elrefaei, M. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 :483-483
[40]   Mismatched Eplets in HLA Antigens May Predict Development of De Novo Donor Specific Antibody (dnDSA) in Kidney Transplant Recipients. [J].
Verbesey, J. ;
Timofeeva, O. ;
Li, D. ;
Javaid, B. ;
Grafals, M. ;
Gilbert, A. ;
Rosen-Bronson, S. ;
Cooper, M. .
TRANSPLANTATION, 2014, 98 :513-513